Loading…
Dogwood Therapeutics, Inc. is projected to rise to $1.91 by 2027, a +32% move from its current price of $1.45. DWTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 6/10/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jun 11 | $1.39 | $1.45 | $1.52 | +0.02% |
| Jun 12 | $1.36 | $1.45 | $1.54 | +0.05% |
| Jun 13 | $1.35 | $1.45 | $1.57 | +0.07% |
| Jun 14 | $1.33 | $1.45 | $1.58 | +0.10% |
| Jun 15 | $1.32 | $1.45 | $1.60 | +0.12% |
| Jun 16 | $1.30 | $1.45 | $1.62 | +0.15% |
| Jun 17 | $1.29 | $1.45 | $1.63 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.29 | $1.45 | $1.63 | +0.17% |
| Week 2 | $1.24 | $1.45 | $1.71 | +0.34% |
| Week 3 | $1.19 | $1.46 | $1.78 | +0.51% |
| Week 4 | $1.16 | $1.46 | $1.84 | +0.69% |
| Week 5 | $1.13 | $1.46 | $1.89 | +0.86% |
| Week 6 | $1.10 | $1.46 | $1.94 | +1.03% |
| Week 7 | $1.08 | $1.47 | $1.99 | +1.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dogwood Therapeutics, Inc. is a development-stage biotechnology company focused on medicines to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic.
The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.
Dogwood Therapeutics trades at $1.50 per share and has a market capitalization of $50.44M, ranking 4575 by market cap. The current price and market position place it among smaller biotechnology stocks. The near term shows bearish indicators, while the longer horizon provides a path to higher prices in several future years.
The year-by-year forecasts show modest to strong upside, with notable upside by 2040 and 2050.
A major floor 34.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 36.6% above — a clean break opens room to run.
A major ceiling 122.1% above — clearing it would confirm fresh momentum.
Key DWTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DWTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.58 | Sell | $1.56 | Sell |
| MA 10 | $1.65 | Sell | $1.62 | Sell |
| MA 20 | $1.73 | Sell | $1.67 | Sell |
| MA 50 | $1.71 | Sell | $1.88 | Sell |
| MA 100 | $2.31 | Sell | $2.45 | Sell |
| MA 200 | $3.90 | Sell | $3.38 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.92 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -190.27 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -20.65 | Sell |
| Bollinger %B (20,2) | -0.06 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 31.14 | Neutral |
| Momentum (10) | -0.33 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.52 | Sell |
| ADX (14) | 14.80 | Neutral |
| ATR (14) | 0.07 | Info |
The near term technical picture is bearish. The RSI14 is 40, and the stock price is below key moving averages (SMA50 is $1.72 and SMA200 is $3.92). In the last 30 days the price traded between $1.12 and $2.02, with a support level at $1.34 and a resistance level at $1.98.
The structure suggests limited upside in the immediate term and potential for further weakness if resistance holds. The current volatility is elevated, reflecting a high-risk environment near the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.34 | $1.45 | $2.06 | 0% | Neutral | |
| $1.43 | $1.91 | $2.75 | +32% | Bullish | |
| $1.26 | $1.77 | $2.68 | +22% | Bullish | |
| $1.14 | $1.67 | $2.63 | +15% | Neutral | |
| $1.05 | $1.58 | $2.59 | +9% | Neutral | |
| $1.03 | $1.60 | $2.70 | +10% | Neutral | |
| $1.14 | $1.83 | $3.17 | +26% | Bullish | |
| $1.26 | $2.09 | $3.71 | +44% | Bullish | |
| $1.34 | $2.30 | $4.16 | +58% | Bullish | |
| $1.24 | $2.19 | $4.04 | +51% | Bullish | |
| $1.56 | $3.12 | $6.28 | +115% | Bullish | |
| $1.79 | $3.97 | $8.99 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| June 2026 | $1.34 | $1.45 | $1.84 | +0.00% |
| July 2026 | $1.29 | $1.55 | $1.93 | +7.08% |
| August 2026 | $1.22 | $1.48 | $1.88 | -4.52% |
| September 2026 | $1.22 | $1.49 | $1.92 | +0.68% |
| October 2026 | $1.28 | $1.58 | $2.05 | +5.73% |
| November 2026 | $1.26 | $1.57 | $2.07 | -0.25% |
| December 2026 | $1.24 | $1.55 | $2.06 | -1.50% |
Click any year to see its month-by-month DWTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DWTX is projected to trade between $1.34 and $2.06, averaging $1.45 — a potential gain of 0% from today's $1.45. Price action looks broadly range-bound.
Dogwood Therapeutics, Inc.'s 2027 outlook centres on $1.91, within a $1.43 to $2.75 range. That is up +32% on the projected 2026 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, DWTX could reach as high as $2.68, with a base case around $1.77 and support toward $1.26 — roughly +22% from $1.45. Momentum favours further upside here.
Expect DWTX to range from $1.14 to $2.63 through 2029. The $1.67 average target implies a +15% move from current prices. That is -6% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The DWTX price prediction for 2030 points to an average of $1.58 (low $1.05, high $2.59) — a potential gain of +9% on today's $1.45. Price action looks broadly range-bound.
In 2031, DWTX is projected to trade between $1.03 and $2.70, averaging $1.60 — a potential gain of +10% from today's $1.45. That is up +1% on the projected 2030 average. A consolidation phase looks the most probable path here.
Dogwood Therapeutics, Inc.'s 2032 outlook centres on $1.83, within a $1.14 to $3.17 range. That is up +14% on the projected 2031 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2033, DWTX could reach as high as $3.71, with a base case around $2.09 and support toward $1.26 — roughly +44% from $1.45. Buyers look set to stay in control over this stretch.
Expect DWTX to range from $1.34 to $4.16 through 2034. The $2.30 average target implies a +58% move from current prices. That is up +10% on the projected 2033 average. Momentum favours further upside here.
The DWTX price prediction for 2035 points to an average of $2.19 (low $1.24, high $4.04) — a potential gain of +51% on today's $1.45. Buyers look set to stay in control over this stretch.
In 2040, DWTX is projected to trade between $1.56 and $6.28, averaging $3.12 — a potential gain of +115% from today's $1.45. That is up +43% on the projected 2035 average. Momentum favours further upside here.
Dogwood Therapeutics, Inc.'s 2050 outlook centres on $3.97, within a $1.79 to $8.99 range. That is up +27% on the projected 2040 average. That marks a +174% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in DWTX today (≈ 689.655172 DWTX) could be worth
$2,737.66
+$1,737.66 (+174%) by 2050 · US Dollar
Based on the average projected DWTX price of $3.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DWTXwould be worth at today's price.
$1,000 invested in DWTX on Jun 9, 2025 (≈ 202.839764 DWTX) would be worth
$294.12
-$705.88 (-70.6%) today · 0.29× · US Dollar
Based on a DWTX entry price of $4.93 vs. today's $1.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.7 | $852.94 | -14.7% |
| 1 month ago | $1.65 | $878.79 | -12.1% |
| 3 months ago | $3.1 | $467.74 | -53.2% |
| 6 months ago | $5.98 | $242.47 | -75.8% |
| 1 year ago | $4.93 | $294.12 | -70.6% |
| All time (5.0y) ago | $153.25 | $9.46 | -99.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DWTX forecast.
Our base-case forecast reaches $2.90 around 2040.
Implied market cap at $2.90: $97.53M
The multi-year forecast shows a gradual path higher from 2026 onward, with 2026 min $1.34, avg $1.50, max $2.15 and ROI 0%, sentiment NEUTRAL. In 2027 the avg rises to $2.00 with a max of $2.89 and ROI 33.2% (Bullish). 2028 shows an avg $1.82, max $2.78, ROI 21.6% (Bullish), and 2030 projects an avg $1.65 with a max of $2.72 and ROI 10% (Neutral).
The forecast continues into 2032 with avg $1.90 and max $3.32 (ROI 26.8%, Bullish) and 2033 with avg $2.18 and max $3.91 (ROI 45.6%, Bullish). By 2040 the avg is $3.23 with a max of $6.57 (ROI 115.5%, Bullish) and by 2050 the avg is $4.12 with a max of $9.44 (ROI 174.4%, Bullish). These long horizon projections imply meaningful upside potential but also carry substantial uncertainty and reflect a high-volatility context (annualized volatility 90%).
The max forecast values illustrate the range of possible outcomes, recognizing that actual results may differ.
Tap a question to reveal the answer.
Avg $1.65; min $1.08; max $2.72; ROI 10%; sentiment NEUTRAL.
Near term 2026 shows avg $1.50 with neutral sentiment; 2027 shows avg $2.00 with Bullish sentiment and ROI 33.2%.
Yes. The 2050 forecast shows max $9.44, with avg $4.12 and ROI 174.4%.
By 2040 the avg is $3.23 with ROI 115.5% and by 2050 the avg is $4.12 with ROI 174.4%.
Current price is $1.50 and market cap is $50.44M.
Dogwood Therapeutics, Inc. Community Discussion
0Share your Dogwood Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.